These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12563361

  • 21. Clodronate : a review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer.
    Dando TM, Wiseman LR.
    Drugs Aging; 2004; 21(14):949-62. PubMed ID: 15554753
    [Abstract] [Full Text] [Related]

  • 22. Clodronate in the prevention and treatment of skeletal metastasis.
    Gulley J, Dahut WL.
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
    [Abstract] [Full Text] [Related]

  • 23. Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients.
    Saarto T, Vehmanen L, Virkkunen P, Blomqvist C.
    Acta Oncol; 2004 Apr; 43(7):650-6. PubMed ID: 15545185
    [Abstract] [Full Text] [Related]

  • 24. Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
    Elomaa I, Blomqvist C, Porkka L, Lamberg-Allardt C, Borgström GH.
    Bone; 1987 Apr; 8 Suppl 1():S53-6. PubMed ID: 2961355
    [Abstract] [Full Text] [Related]

  • 25. [Value of Clodronate in the treatment of bone metastasis].
    Pouillart P, Beuzeboc P.
    Bull Cancer; 1991 Apr; 78(8):737-41. PubMed ID: 1834287
    [Abstract] [Full Text] [Related]

  • 26. [Use of clodronic acid in mineral metabolism conditions: state of the art in 2000].
    Brandi ML.
    Minerva Med; 2001 Aug; 92(4):251-68. PubMed ID: 11535969
    [Abstract] [Full Text] [Related]

  • 27. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A.
    Cancer Treat Rev; 2008 Aug; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [Abstract] [Full Text] [Related]

  • 28. Bisphosphonates and breast cancer incidence and recurrence.
    Chlebowski RT, Col N.
    Breast Dis; 2011 Aug; 33(2):93-101. PubMed ID: 22142660
    [Abstract] [Full Text] [Related]

  • 29. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
    Diel IJ, Solomayer EF, Bastert G.
    Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The role of bisphosphonates in breast cancer.
    Coleman RE.
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [Abstract] [Full Text] [Related]

  • 34. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
    Leppä S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I.
    Breast Cancer Res Treat; 2005 Mar; 90(2):117-25. PubMed ID: 15803358
    [Abstract] [Full Text] [Related]

  • 37. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS.
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer.
    Liauw W, Segelov E, Lih A, Dunleavy R, Links M, Ward R.
    BMC Cancer; 2005 Jul 28; 5():89. PubMed ID: 16048654
    [Abstract] [Full Text] [Related]

  • 40. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005 Jul 28; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.